v3.26.1
Financial Instruments
12 Months Ended
Mar. 31, 2026
Financial Instruments [Abstract]  
Financial Instruments FINANCIAL INSTRUMENTS
Cash and Cash Equivalents
As of March 31, 2026 and 2025, our cash and cash equivalents were $2,864 million and $2,136 million, respectively. Cash equivalents were valued using quoted market prices or other readily available market information.
Short-Term Investments
Short-term investments consisted of the following as of March 31, 2026 and 2025 (in millions):
 
As of March 31, 2026
As of March 31, 2025
 Cost or
Amortized
Cost
Gross UnrealizedFair
Value
Cost or
Amortized
Cost
Gross UnrealizedFair
Value
 GainsLossesGainsLosses
Corporate bonds$52 $— $— $52 $46 $— $— $46 
U.S. Treasury securities33 — — 33 12 — — 12 
U.S. agency securities— — — — — — 
Foreign government securities— — — — 
Asset-backed securities24 — — 24 50 — — 50 
Short-term investments$116 $— $— $116 $112 $— $— $112 
The following table summarizes the amortized cost and fair value of our short-term investments, classified by stated maturity as of March 31, 2026 and 2025 (in millions):
 
As of March 31, 2026
As of March 31, 2025
 Amortized
Cost
Fair
Value
Amortized
Cost
Fair
Value
Short-term investments
Due within 1 year$70 $70 $46 $46 
Due 1 year through 5 years45 45 63 63 
Due after 5 years
Short-term investments$116 $116 $112 $112